$ 1,540.16
Details
Capto L is suitable for the capture of a wide range of antibody fragments such as Fabs, single-chain variable fragments (scFv), and domain antibodies (Dabs).High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of medium. Enables a platform approach for purification of antibody fragments. Increased productivity, process economy, and process design flexibility due to rigid matrix. The high binding capacity and selectivity for a broad range of antibody fragments makes Capto L an excellent capture platform for antibody fragments containing kappa light chains.Using Capto L requires minimal optimization and it produces high purity in one separation step.Capto L provides several advantages in manufacturing processes because the high selectivity of affinity capture reduces the number of subsequent polishing steps.
